WHAT’S KNOWN? (what is already known about this subject?)
Current research indicates that SARS-CoV-2 infection induces various processes of cellular damage mediated by inflammation derived from the activity of the immune system, and that these events potentiate cellular damage in various tissues such as the endothelium, lungs, heart, etc. In severe cases, it has been indicated that patients have leukopenia, however, the effect of the infection on the cells of the immune system and in the early stages of the disease has not been evaluated.